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The amino terminus of bovine pro-opiomelanocortin (N-POMC’-“) is partially processed in the intermediate lobe of the pituitary to N-POMC’WJ” 
and lys-y,-melanotropin. Two pools of N-POMC’..” were isolated which were differentially glycosylated at threonine45, while N-POMC’A” isolated 
from bovine intermediate lobe extracts existed in a non-glycosylated form. This suggested that differential O-linked glycosylation of N-POMC’.” 
may regulate cleavage at the ArgJv-Lys’” processing site. We tested this hypothesis by incubating N-POW?” glycoforms with purified pro- 
opiomelanocortin converting enzyme. Only non-O-glycosylatcd N-POMC’-” and 0-glycosylatcd N-POMC’-” with truncated oligosaccharide 
sidechains were sensitive to cleavage and generaied predominantly lys-y,-melanotropin, identified by high-performance liquid chromatography. 
These data provide the first functional evidence to support a role for differential O-linked glycosylation in the regulation of the processing of the 
N-terminus of bovine POMC. 
Neuropeptidc; Maturation: Pro-opiomelanocortin processing; O-Linked glycosylation 
1. INTRODUCTION 
Most endocrine and neuroendocrine peptides are syn- 
thesized as larger precursors [I-S]. In many cases, the 
precursor protein contains multiple copies of a biologi- 
tally active peptide, such as the enkephalin peptides in 
proenkephalin [4], or several unique peptides with dis- 
tinct, although often synergistic actions as is seen in the 
pro-opiornelanocortin precursor (POMC, [5J). These 
biologically active peptides are often flanked by pairs of 
basic amino acids which are thought to act as recogni- 
tion sites for cleavage by endoproteases. Characteriza- 
tion of biologically active peptides in the central and 
peripheral nervous systems and other peripheral tissues 
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has indicated that not all paired basic residues are 
cleaved. Furthermore, it has been shown that the same 
pro-protein precursor can be processed at different 
pairs of basic residues in different areas of the brain or 
in peripheral tissues to release different peptide 
products [6-91. To better understand the mechanisms 
involved in alternate processing of pro-hormones/neu- 
ropeptides, we have chosen to study the processing of 
the ACTH/endorphin precursor in the pituitary gland. 
In the anterior lobe of the pituitary gland, POMC is 
processed at paired basic residues predominantly to 
ACTH and ,SLPH, while in the intermediate lobe and 
brain these two peptides are further processed to a- 
MSH, CLIP, y-LPH and the endorphins [IO]. The N- 
terminus of POMC is aiso processed differently in the 
two lobes. Isolation and composition analysis of the 
N-terminal peptides in the bovine pituitary demon- 
strated that N-POMC’-77, N-POMC’49 and lys-y,- 
MSH were the major peptides in the intermediate lobe 
while the anterior lobe contained mainly N-POMC’-77 
[I l-151. A small proportion of lys-y,-MSH was found 
to be processed further to lys-y,-MSH in the interme- 
diate lobe [13,16]. Detailed analysis of the N-terminal 
peptides revealed two forms of N-POMC’-77 in the in- 
termediate lobe; the major form (80%) was glycosylated 
at threonine4s (O-linked) and asparagine”’ (N-linked) 
while the minor form was glycosylated only at aspara- 
gine”’ [12]. However, only a single species of 
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Fig. I. Differential O-linked glycosylation of N-POMC?” at threoni- 
ne4J regulates the generation of N-POMC?” and lys-y,-MSH. 
N-POFVIC’-~~ was isolated which was unglycosylated 
[l I] (Fig. 1). This observation has recently been con- 
firmed by others [IT]. This suggested that only N- 
POMC’-” which lacked the O-linked glycosylation of 
threonine45 was capable of being processed to N- 
POMC’-4y and various forms of y-MSH [18]. In the 
present study, we tested this hypothesis by incubating 
enriched species of principally glycosylated or non-gly- 
cosylated N-POMC’-” with purified pro-opiomelano- 
cortin converting enzyme which we have previously 
shown to cleave N-POMC’~” (as a mixed glycoform 
substrate) at paired basic residues [19]. We present data 
to support a role for O-linked glycosylation in the 
regulation of cleavage of pro-opiomelanocortin. 
2. MATERIALS AND METHODS 
N-POMC’ J’ was prepared from bovine posterior pituitaries cssen- 
tially as described previously using a combination of reversed-phase 
and ion-exchange batch extraction procedures followed by reversed- 
phase HPLC [It.1 31. While homogeneous in terms of peptide content, 
the chromatograpbic behavior of this material clearly indicated a 
considerable degree of heterogeneity. Analysis of pcptides derived 
from N-POMC’-” following hydrolysis with trypsin rcvealcd that this 
heterogeneity was due to the nature and extent of glycosylation. N- 
POMC’-” was completely N-glycosylated at asparagine residue 65 as 
shown by analysis of the tryptic fragment G5-77. Analysis of the 
tryptic fragment 23-49 which bears the O-linked site at residue 45 
demonstrated two forms of this peptide, either glycosylated or non- 
glycosylated at threonine rcsiduc 45. The N-POMC’-” glycoforms 
were further separated by reversed-phase HPLC on apBondapak C,, 
column which was eluted with a li.lear gradient over 2 h from 8-48% 
acetonitrile containing0.01 M ammonium bicarbonate pW 8 at a flow 
rate of I.5 ml per min. 
The O-linked glycoforms of N-POMC’-77 were trypsinized and the 
tryptic fragments 23-49 wcrc analyzed for sialic acid, and neutral and 
amino sugars after hydrolysis with censtant boiling 6 M HCI or 2 M 
trifiuoroacetic acid respectively, a HPAE-PAD high pH anion-ex- 
change system with pulsed amperometric detection (Dionex Corp, 
Sunnyvale, CA) was used to separate and quantitate the various su- 
gars [20]. 
2.3. En~yyrtle incrrhotiom 
Pro-opiomelanocortin converting enzyme was purified from bovine 
intermediate lobe secretory vesicles as described previously [l9], I 
nmol of either the 0-glycosylatcd or non-O*glycosylated substrate was 
digested with -100 ng of purified pro-opiomelanocortin converting 
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Fig. 2. Generation of y-MSH immunoreactivity following incubation 
of N-POMC’.” enriched in either the O-linked (-+) or non-O-linked 
(D) threonine” glycoform with pro-opiomelanocortin converting cn- 
zyme. Each time point represents the total amount of y-MSH immu- 
noreactivity in the original incubation volume (200 ,uI). 
enzyme in 0.1 M sodium citrate/HCI, pH 4.5 in a linal volume of 200 
,uI of 37OC. At various time intervals (see results). 20~1 aliquots were 
removed and acidified with an equal volume of 50 mM acetic acid. 
Samples were quantitated by radioimmunoassay. either directly using 
antibody MC7 raised against y,-MSH and which recognized y,-MSH 
and lys-y,-MSH [l9]. or following separation ofthe digestion products 
by reversed phase HPLC. Samples were separated on a Bio-Rad Hi- 
Pore RP-318 column (5 x 250 mm) using a gradient from O-20% 
Solvent B in IO min and then 2045% Solvent B in 80 min at a flow 
rate of I ml/min. Solvent A was 0. I % trifluoroacetic acid and Solvent 
B was 80% acetonitrile in 0.1% trifluoroacetic acid. 0.5 ml fractions 
wcrc collected for radioimmunoassay. 
3. RESULTS AND DISCUSSION 
Previous studies had demonstrated that the N-termi- 
nal fragment of bovine pro-opiomelanocortin (N- 
POMC’-77) from the neurointermediate lobe of the pi- 
tuitary was differentially glycosylated at threonine resi- 
due 45 [I 21. Using reverse-phase HPLC (see section 2), 
purified N-POMC’-” was further resolved as a broad 
peak over approximately 45 fractions. The leading edge 
of this peak (i.e. the first 15 fractions, Pool A) contained 
N-POMC’-” which was essentially 100% Q-glyco- 
sylated at threonine4” and the trailing edge (i.e. the last 
I.5 fractions, Pool B) contained N-POMC’-” which con- 
tained -20% Q-linked oligosaccharide. The extent of O- 
linked glycosylation was determined by HPLC separa- 
tion and analysis of the glucosamine and galactosamine 
content in the tryptic fragment (residues 23-49) which 
contained the O-linked glycosylation site. Resolution of 
the O-linked glycosylated tryptic peptide (rather than 
intact N-POMC?“) into several forms by HPLC sug- 
gested considerable heterogeneity within the oligosac- 
charide structure of these two pools. While the low 
levels of peptide made analysis difficult, we estimate 
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that approximately 80% of the 0-glycosylated N- 
POMC’-” in pool A contained a simple oligosaccharide 
structure composed of galactosamine and glucosamine. 
The remaining 20% was composed of truncated oligo- 
saccharide structures. The presence of truncated O- 
linked oligosaccharide structures in pool A was sub- 
stantiated as follows. The leading and trailing edges of 
the u.v.peak containing the 23-49 tryptic fragments 
from pool A were subjected to neutral, amino and sialic 
acid sugar anaysis. The following compositions were 
found (mol sugarlmol peptide): leading edge: Gal Nat 
2.5, Glc Nat 1.7, Gal 2.6, Man 4.2, Sialic acid 0.8, 
trailing edge: Gal Nat 1.5, Gls Nat 1 .l, Gal 1.7, Man 
3.2, Sialic acid 0.3, indicating the presence of N- 
POMC’-” forms with truncated O-linked oligosaccari- 
des. These truncated structures were probably genera- 
ted during the initial tissue extraction by acid hydrolysis 
of glycosidic linkages. The fine structural carbohydrate 
analyses are not critical to the present study and will be 
presented elsewhere (A. Dell and H.P.9. Bennett, in 
preparation), but the somewhat simplistic divisions of 
the O-linked N-POMC’.“’ glycoforms are necessary for 
interpretation of the processing results. Thus, for incu- 20 25 30 
bations with purified pro-opiomelanocortin converting Ketentisn Time (mia) 
enzyme we had two substrate pools: Pool A consisted 
of 100% O-glycosylated N-POMC”.” of which 20% was Fig. 3. HPLC identification of y-MSH immunoreaclive products 
comprised of molecules with truncated sugars; and pool generated from bovine N-POMC“” by purified pro-opiomclano- 
B consisted of 80% non-0-glycosylated N-POMC’ “. 
cortin converting enzyme. HPLC profiles of a-MSH immunoreaclivc 
N-POMC’ ” glycoform substrates isolated from paral- 
products generated from O-glycosylated (A) and non-0-glycosylsted 
lel purifications were used for incubations with pro- 
(E) N-POMC’.“. The elution position of lys-y,-MSH is shown. 
opiomelanocortin converting enzyme and for trypsini- noreactivity generated by pro-opiomelanocortin con- 
zation followed by amino and neutral sugar analysis. verting enzyme. However, pool A contains a heteroge- 
Incubation of the non-0-glycosylated enriched pool neous mixture of O-linked N-POMC’-” glycoforms and 
B N-POMC’-” with bovine pro-opiomelanocortin con- we attribute the conversion of between 20-30% of the 
verting enzyme resulted in the generation of I/-MSH substrate to the presence of truncated O-linked oligo- 
immunoreactive material (Fig. 2). The initial produc- saccharide structures which represented approximately 
tion of y-MSH immunoreactive material was very rapid 20% of this pool. 
as demonstrated by the ‘zero’ time point which more Identification of the y-MSH immunoreactive pro- 
accurately represents a -5 s incubation. By 20 min, y- ducts was determined following HPLC. Both pools of 
MSH immunoreactivity had reached a maximum of 790 N-POMC’-” were processed to identical products. The 
pmol. This represented 79% of the total moles of added major immunoreactive peak had a retention time identi- 
substrate. In a second experiment, 81% (812 pmol) of cal to human lys-y,-MSH standard (Fig. 3). An earlier 
pool B N-POMC’-” was converted to y-MSH immu- eluting peak, with a retention time of 22 min may repre- 
noreactive material. As pool Ip N-POMC’-” contained sent an oxidized lys-y,-MSH species. y-MSH immuno- 
-20% O-glycosylated N-POMC’-” these results are con- reactive material with a similar retention time, eluting 
sistent with the hypothesis that pro-opiomelanocortin just before the human lys-y,-MSH peptide standard has 
converting enzyme is unable to cleave 0-glycosylated been seen in acid extracts of rat pituitary (Estivariz, 
N-POMC’-“. Incubation of the O-glycosylated pool A unpublished observation) and following incubations of 
N-POMC’-” substrate with pro-opiomelanocortin con- the mixed glycoform substrate with pro-opiomelano- 
verting enzyme resulted in the generation of I/-WISH cortin converting enzyme [21]. No immunoreactivity 
immunoreactive material. After a 20 min incubation, was seen with a retention time which corresponded to 
the amount of y-MSH immunoreactivity generated y,-MSH in agreement with our earlier work [19]. 
from 0-glycosylated enriched N-POMC’-” was -305 These data strongly support a role of Q-linked gly- 
pmol (Fig. 2) and -195 pmol (data not shown) in two cosylation in the regulation of cleavage of the N-ter- 
separate experiments. As pool A N-POMC’-“’ wa.s minus of the prohormone precursor, pro-opiomelano- 
shown to be 100% 0-glycosylated, our hypothesis cortin, in bovine intermediate pituitary. The results sug- 
would predict that there should be no y-MSH immu- gest a more complicated mechanism than our initial 
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